B Braun 5% Glucose Intravenous Infusion BP 250 mL Bottle Australia - engelsk - Department of Health (Therapeutic Goods Administration)

b braun 5% glucose intravenous infusion bp 250 ml bottle

b braun australia pty ltd - glucose monohydrate, quantity: 55 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. may also be used as solvents for intravenously administered drugs where compatibility has been established.

B Braun 5% Glucose Intravenous Infusion BP 100 mL Bottle Australia - engelsk - Department of Health (Therapeutic Goods Administration)

b braun 5% glucose intravenous infusion bp 100 ml bottle

b braun australia pty ltd - glucose monohydrate, quantity: 55 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. may also be used as solvents for intravenously administered drugs where compatibility has been established.

Glucose 5 % w/v Viaflo sol. perf. i.v. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glucose 5 % w/v viaflo sol. perf. i.v.

baxter sa-nv - glucose monohydraté 55 mg/ml - eq. glucose anhydre 50 g/l - solution pour perfusion - glucose monohydraté 55 mg/ml - carbohydrates

Fludeoxyglucose (18F) RTM 200 MBq/ml sol. inj. i.v. flac. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fludeoxyglucose (18f) rtm 200 mbq/ml sol. inj. i.v. flac.

radboud translational medicine b.v. - fludésoxyglucose (f-18) 200 mbq/ml - solution injectable - 200 mbq/ml - fludésoxyglucose (f-18) 200 mbq/ml - fludeoxyglucose (18f)

FLUDEOXYGLUCOSE [F-18] FDG INJECTION Solution Canada - fransk - Health Canada

fludeoxyglucose [f-18] fdg injection solution

thunder bay regional health sciences centre - fludéoxyglucose 18f - solution - 0.5gbq - fludéoxyglucose 18f 0.5gbq - roentgenography

FLUDEOXYGLUCOSE [F-18] FDG INJECTION Solution Canada - fransk - Health Canada

fludeoxyglucose [f-18] fdg injection solution

thunder bay regional health sciences centre - fludéoxyglucose 18f - solution - 0.5gbq - fludéoxyglucose 18f 0.5gbq - roentgenography

Glucose Injection (Baxter) New Zealand - engelsk - Medsafe (Medicines Safety Authority)

glucose injection (baxter)

baxter healthcare ltd - glucose monohydrate 10% - solution for infusion - 10 % - active: glucose monohydrate 10% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.

Glucose Injection (Baxter) New Zealand - engelsk - Medsafe (Medicines Safety Authority)

glucose injection (baxter)

baxter healthcare ltd - glucose monohydrate 25% - solution for infusion - 25 % - active: glucose monohydrate 25% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.

Glucose Injection (Baxter) New Zealand - engelsk - Medsafe (Medicines Safety Authority)

glucose injection (baxter)

baxter healthcare ltd - glucose monohydrate 50% - solution for infusion - 50 % - active: glucose monohydrate 50% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.

Glucose Injection (Baxter) New Zealand - engelsk - Medsafe (Medicines Safety Authority)

glucose injection (baxter)

baxter healthcare ltd - glucose monohydrate 70% - solution for infusion - 70 % - active: glucose monohydrate 70% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.